Seeing Is Believing
BDTX is currently covered by 3 analysts with an average price target of $14.43. This is a potential upside of $9.05 (168.22%) from yesterday's end of day stock price of $5.38.
Black Diamond Therapeutics's activity chart (see below) currently has 8 price targets and 18 ratings on display. The stock rating distribution of BDTX is 20% HOLD and 80% BUY.
Analysts average stock forecasts to be materialized ratio is 26.39% with an average time for these price targets to be met of 71.25 days.
Highest price target for BDTX is $16, Lowest price target is $10, average price target is $14.43.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 08-Apr-2024. First documented stock forecast 24-Feb-2020.
Currently out of the existing stock ratings of BDTX, 2 are a HOLD (20%), 8 are a BUY (80%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
$10.65 (199.07%)
10
10 days ago
2/9 (22.22%)
$10.65 (199.07%)
94
Buy
12
$6.65 (124.30%)
11
1 months ago
0/4 (0%)
$7.3 (155.32%)
Buy
10
$4.65 (86.92%)
2
9 months 19 days ago
2/4 (50%)
$4.95 (98.02%)
117
Buy
24
$22.42 (1418.99%)
44
2 years 10 months 29 days ago
1/3 (33.33%)
$13.28 (63.42%)
74
What is BDTX (Black Diamond Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BDTX (Black Diamond Therapeutics) with a proven track record?
Which analyst has the current lower performing score on BDTX (Black Diamond Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BDTX (Black Diamond Therapeutics)?
Which analyst is the currently most bullish on BDTX (Black Diamond Therapeutics)?
Which analyst is the currently most reserved on BDTX (Black Diamond Therapeutics)?